Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Porter

Showing results (1351-1360 of 1,461) with videos related to

Pageof 147
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smokingRichard D Hurt, James E Krook, Ivana T Croghan, et al.
Science (New York, N.Y.)|February 6, 2016
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiencyMichael Bidinosti, Paolo Botta, Sebastian Krüttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancerEva Grunfeld, Jim A Julian, Gregory Pond, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Feature-Driven Whole-Tissue Imaging with Subcellular ResolutionJinlong Lin, Zach Marin, Xiaoding Wang, et al.
Bioinformatics (Oxford, England)|March 24, 2019
ORE identifies extreme expression effects enriched for rare variantsF Richter, G E Hoffman, K B Manheimer, et al.
Plos One|January 20, 2018
The Congenital Heart Disease Genetic Network Study: Cohort descriptionThanh T Hoang, Elizabeth Goldmuntz, Amy E Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2020
Discovery of a series of ester-substituted NLRP3 inflammasome inhibitorsDavid Harrison, Nicolas Boutard, Krzysztof Brzozka, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.
JACC. Basic to Translational Science|April 25, 2026
Inhibition of Cyclophilin D Rescues Cardiac Function and Bioenergetic Defects Caused by Neonatal HypoxiaJonathan R Burris, Gisela Beutner, Min Yee, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2011
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disordersRomano Di Fabio, Annalisa Pellacani, Stefania Faedo, et al.
Pageof 147

Showing results (1351-1360 of 1,461) with videos related to

Sort By:
Pageof 147
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smokingRichard D Hurt, James E Krook, Ivana T Croghan, et al.
Science (New York, N.Y.)|February 6, 2016
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiencyMichael Bidinosti, Paolo Botta, Sebastian Krüttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancerEva Grunfeld, Jim A Julian, Gregory Pond, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Feature-Driven Whole-Tissue Imaging with Subcellular ResolutionJinlong Lin, Zach Marin, Xiaoding Wang, et al.
Bioinformatics (Oxford, England)|March 24, 2019
ORE identifies extreme expression effects enriched for rare variantsF Richter, G E Hoffman, K B Manheimer, et al.
Plos One|January 20, 2018
The Congenital Heart Disease Genetic Network Study: Cohort descriptionThanh T Hoang, Elizabeth Goldmuntz, Amy E Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2020
Discovery of a series of ester-substituted NLRP3 inflammasome inhibitorsDavid Harrison, Nicolas Boutard, Krzysztof Brzozka, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 studyKimberly A Porter, Stephen R Cole, Joseph J Eron, et al.
JACC. Basic to Translational Science|April 25, 2026
Inhibition of Cyclophilin D Rescues Cardiac Function and Bioenergetic Defects Caused by Neonatal HypoxiaJonathan R Burris, Gisela Beutner, Min Yee, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2011
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disordersRomano Di Fabio, Annalisa Pellacani, Stefania Faedo, et al.
Pageof 147